| 1558 |
1420: Reduced, SHP activity |
1421: Activated, LXR |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 673 |
673: Reduced, Spawning behavior |
674: Reduced, Ability to attract spawning mates |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1641 |
1005: Reduced, Swimming performance |
1467: Growth, reduction |
Aug 3, 2017 |
Aug 3, 2017 |
1 AOP
|
| 1642 |
1005: Reduced, Swimming performance |
636: Decreased, survival |
Aug 3, 2017 |
Aug 3, 2017 |
1 AOP
|
| 2081 |
1005: Reduced, Swimming performance |
360: Decrease, Population growth rate |
Apr 21, 2020 |
Jun 4, 2020 |
1 AOP
|
| 2212 |
1005: Reduced, Swimming performance |
351: Increased Mortality |
Nov 30, 2020 |
Sep 8, 2021 |
5 AOPs
|
| 3674 |
1005: Reduced, Swimming performance |
2382: Increase, nerve spasm |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 587 |
586: Reduced, swimming speed |
587: Reduced, feeding 1 |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 588 |
586: Reduced, swimming speed |
588: Increased, predation |
Nov 29, 2016 |
Dec 3, 2016 |
3 AOPs
|
| 1895 |
1631: Reduction fo Pigmentation pattern |
360: Decrease, Population growth rate |
May 3, 2019 |
May 3, 2019 |
1 AOP
|
| 1893 |
1629: Reduction in melanin level |
1630: Reduction of melanosome level |
May 3, 2019 |
May 3, 2019 |
1 AOP
|
| 396 |
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1) |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 1638 |
1464: Reduction of collagen crosslinking |
1465: Weak collagen matrix |
Aug 3, 2017 |
Aug 3, 2017 |
1 AOP
|
| 1892 |
1628: Reduction of L-Dopaquinone |
1629: Reduction in melanin level |
May 3, 2019 |
May 3, 2019 |
1 AOP
|
| 1894 |
1630: Reduction of melanosome level |
1631: Reduction fo Pigmentation pattern |
May 3, 2019 |
May 3, 2019 |
1 AOP
|
| 5 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
219: Reduction, Plasma 17beta-estradiol concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
6 AOPs
|
| 3326 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
285: Reduction, Vitellogenin synthesis in liver |
Jul 26, 2024 |
Jul 26, 2024 |
1 AOP
|
| 3624 |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
1696: Decrease of egg production and cummulative fecundity |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 2145 |
1789: Reduction, E2 Synthesis by the undifferentiated gonad |
1790: Increased, Differentiation to Testis |
Jun 15, 2020 |
Jul 11, 2022 |
1 AOP
|
| 3229 |
1611: Reduction, androstenedione |
1690: Decrease, circulating testosterone levels |
May 24, 2024 |
Apr 8, 2025 |
1 AOP
|
| 36 |
28: Reduction, Angiogenesis |
110: Impairment, Endothelial network |
Nov 29, 2016 |
Jan 18, 2022 |
1 AOP
|
| 3683 |
28: Reduction, Angiogenesis |
2383: Increase, Hemopericardium |
Oct 30, 2025 |
Oct 30, 2025 |
1 AOP
|
| 59 |
49: Reduction, Ca and HCO3 transport to shell gland |
106: Reduction, Eggshell thickness |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 438 |
447: Reduction, Cholesterol transport in mitochondria |
413: Reduction, Testosterone synthesis in Leydig cells |
Nov 29, 2016 |
Dec 2, 2016 |
2 AOPs
|
| 3517 |
447: Reduction, Cholesterol transport in mitochondria |
2319: Decreased, Pregnenolone levels |
Apr 8, 2025 |
Apr 8, 2025 |
None
|